178 related articles for article (PubMed ID: 23627607)
21. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ
Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165
[TBL] [Abstract][Full Text] [Related]
22. Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.
Chen N; Chon HS; Xiong Y; Marchion DC; Judson PL; Hakam A; Gonzalez-Bosquet J; Permuth-Wey J; Wenham RM; Apte SM; Cheng JQ; Sellers TA; Lancaster JM
Oncol Rep; 2014 Jan; 31(1):376-83. PubMed ID: 24220856
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
24. Down-regulated miR-9 and miR-433 in human gastric carcinoma.
Luo H; Zhang H; Zhang Z; Zhang X; Ning B; Guo J; Nie N; Liu B; Wu X
J Exp Clin Cancer Res; 2009 Jun; 28(1):82. PubMed ID: 19531230
[TBL] [Abstract][Full Text] [Related]
25. Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content.
Kakimoto Y; Tanaka M; Kamiguchi H; Ochiai E; Osawa M
PLoS One; 2016; 11(9):e0163125. PubMed ID: 27649415
[TBL] [Abstract][Full Text] [Related]
27. BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer.
Sugio A; Iwasaki M; Habata S; Mariya T; Suzuki M; Osogami H; Tamate M; Tanaka R; Saito T
Gynecol Oncol; 2014 Sep; 134(3):615-23. PubMed ID: 24992675
[TBL] [Abstract][Full Text] [Related]
28. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract][Full Text] [Related]
29. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
Boisen MK; Dehlendorff C; Linnemann D; Schultz NA; Jensen BV; Høgdall EV; Johansen JS
BMC Cancer; 2015 Dec; 15():1024. PubMed ID: 26714641
[TBL] [Abstract][Full Text] [Related]
31. [DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx].
Li L; Zhang ZM; Liu Y; Wei MH; Xue LY; Zou SM; Di XB; Han NJ; Zhang KT; Xu ZG; Gao YN
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):391-5. PubMed ID: 21055156
[TBL] [Abstract][Full Text] [Related]
32. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
Xu CZ; Xie J; Jin B; Chen XW; Sun ZF; Wang BX; Dong P
Int J Clin Exp Pathol; 2013; 6(7):1351-61. PubMed ID: 23826416
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
Nam EJ; Lee M; Yim GW; Kim JH; Kim S; Kim SW; Kim YT
BMC Med Genomics; 2012 May; 5():18. PubMed ID: 22643117
[TBL] [Abstract][Full Text] [Related]
34. Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors.
Timofeeva AV; Fedorov IS; Asaturova AV; Sannikova MV; Tregubova AV; Mayboroda OA; Khabas GN; Frankevich VE; Sukhikh GT
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569592
[TBL] [Abstract][Full Text] [Related]
35. Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.
Zhu M; Zhang N; He S
Pathol Res Pract; 2014 Dec; 210(12):909-15. PubMed ID: 25115709
[TBL] [Abstract][Full Text] [Related]
36. miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.
Braicu OL; Budisan L; Buiga R; Jurj A; Achimas-Cadariu P; Pop LA; Braicu C; Irimie A; Berindan-Neagoe I
Onco Targets Ther; 2017; 10():4225-4238. PubMed ID: 28894379
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression profiles of multiple system atrophy from formalin-fixed paraffin-embedded samples.
Wakabayashi K; Mori F; Kakita A; Takahashi H; Tanaka S; Utsumi J; Sasaki H
Neurosci Lett; 2016 Dec; 635():117-122. PubMed ID: 27773796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
